Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by GILLIS JONATHAN. Insider active across 1 company, notably MapLight Therapeutics, Inc.. Aggregated, 7 filings have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €1.9m. History available since 27 October 2025. The latest transaction was filed on 28 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
7 of 7 declarations
GILLIS JONATHAN is a declarant linked to MapLight Therapeutics, Inc. (XNAS), where the listed role is CAAO and PAO. The 6 filings recorded, covering the period from 2026-04-17 to 2026-04-29 in the recent filings sampled, correspond to sales for a total of EUR 1861894 and no purchases.